Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 18 years or older.
- People who have been diagnosed with primary invasive breast cancer or a non-invasive breast condition called ductal carcinoma in situ (DCIS), confirmed by a tissue test.
- People whose cancer is at an early to intermediate stage, has not spread to distant parts of the body, and involves limited or no lymph node involvement (confirm with trial site for exact staging details).
- People who are planned to have a type of breast removal surgery that preserves the nipple, followed by immediate reconstruction.
- People where, during surgery, a tissue sample taken from the nipple area confirms the presence of invasive cancer or DCIS.
- People who are generally active and able to carry out daily activities with no or minimal limitations (this is measured using a standard medical scale called the ECOG scale, scores 0–1).
- People who are willing to provide written consent to participate in the trial voluntarily.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People where there are signs — either on physical examination or imaging — that the cancer may involve the areola (the darker skin around the nipple) or the skin of the breast.
- People who have a type of breast cancer called inflammatory breast cancer.
- People who are currently pregnant or breastfeeding.
- People with a serious medical or psychiatric condition that, in the treating doctor's judgment, would make safe participation or following the trial requirements difficult.
- People with serious uncontrolled health conditions where life expectancy is estimated to be less than 5 years.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ke Wang, MD, Department of Breast Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine
Phone: +86-1356711447
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Local Recurrence Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.